On Wednesday, Organogenesis Holdings Inc (ORGO) stock saw a modest uptick, ending the day at $4.43 which represents a slight increase of $0.98 or 28.41% from the prior close of $3.45. The stock opened ...

This private placement offering represents a significant move by Organogenesis Holdings Inc. to secure strategic growth ...

Organogenesis Holdings Inc. has secured a $130 million private placement deal with Avista Healthcare Partners to bolster its strategic growth, repay debt, and repurchase shares. This investment, ...

Organogenesis Holdings ( (ORGO) ) has released its Q3 earnings. Here is a breakdown of the information Organogenesis Holdings presented to its ...

ORGO earnings call for the period ending September 30, 2024. Organogenesis ( ORGO -1.43%) Q3 2024 Earnings Call Nov 12, 2024, ...

Organogenesis (ORGO) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.02 per share a year ago.

IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon”) (Nasdaq: ELDN) today reported its third quarter 2024 operating and financial results and reviewed recent ...

DENVER, Nov. 12, 2024 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM), a leading provider of SaaS solutions for service SMBs, announced today the hiring of Josh McCarter as the leader of its ...

CANTON, Mass. (AP) — CANTON, Mass. (AP) — Organogenesis Holdings Inc. (ORGO) on Tuesday reported profit of $12.3 million in its third quarter. The Canton, Massachusetts-based company said it had net ...

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of ...

Organogenesis (NASDAQ:ORGO – Get Free Report) will release its earnings data after the market closes on Tuesday, November ...